Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 231.0
(0.87%)
JPY 231.0
(0.87%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 7.73 Billion | 8.66 Billion | 8.38 Billion | 8.89 Billion | 10.91 Billion | 10.74 Billion |
| Cost of Revenue | 4.19 Billion | 4.55 Billion | 4.02 Billion | 4.4 Billion | 4.72 Billion | 4.62 Billion |
| Gross Profit | 3.54 Billion | 4.1 Billion | 4.35 Billion | 4.48 Billion | 6.19 Billion | 6.11 Billion |
| Operating Expenses | 3.73 Billion | 3.96 Billion | 4.36 Billion | 5.24 Billion | 7.19 Billion | 6.5 Billion |
| Selling, General and Administrative Expenses | 3.22 Billion | 3.32 Billion | 3.77 Billion | 4.53 Billion | 5.39 Billion | 4.83 Billion |
| Research and Development Expenses | 513.31 Million | 580.45 Million | 593.95 Million | 641.51 Million | 1.72 Billion | 1.6 Billion |
| Other Expenses | - | 15.66 Million | 46.36 Million | 104.7 Million | 47.13 Million | -14.7 Million |
| Cost and Expenses | 7.93 Billion | 8.51 Billion | 8.39 Billion | 9.64 Billion | 11.91 Billion | 11.13 Billion |
| Operating Income | -195.51 Million | 141.46 Million | -13.38 Million | -754.94 Million | -996.27 Million | -391.01 Million |
| Interest Expense | 531 Thousand | 578 Thousand | 575 Thousand | 569 Thousand | 669 Thousand | 1.66 Million |
| Income Tax Expense | 49.89 Million | 73.31 Million | 46.31 Million | -101.15 Million | 745.49 Million | -48.51 Million |
| Earnings before Tax | 158.85 Million | 211.57 Million | 284.85 Million | -703 Million | -911.04 Million | -229.79 Million |
| Net Income | 108.95 Million | 138.25 Million | 238.54 Million | -601.85 Million | -1.65 Billion | -181.28 Million |
| Earnings Per Share Basic | 3.14 | 3.98 | 6.87 | -17.34 | -47.73 | -5.22 |
| Earnings Per Share Diluted | 3.14 | 3.98 | 6.87 | -17.34 | -47.73 | -5.22 |
| Weighted Average Shares Outstanding | 34.7 Million | 34.7 Million | 34.7 Million | 34.7 Million | 34.7 Million | 34.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.7 Million | 34.7 Million | 34.7 Million | 34.7 Million | 34.7 Million | 34.7 Million |
| Gross Margin | 0.46 | 0.47 | 0.52 | 0.50 | 0.57 | 0.57 |
| EBIT Margin | 0.07 | 0.07 | 0.07 | -0.01 | -0.04 | 0.01 |
| Profit Margin | 0.01 | 0.02 | 0.03 | -0.07 | -0.15 | -0.02 |
| EBITDA | 570.97 Million | 575.8 Million | 755.51 Million | -218.12 Million | -442.18 Million | 243.09 Million |
| Earnings Before Tax Margin | -0.03 | 0.02 | -0.00 | -0.08 | -0.09 | -0.04 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.88 Billion | 7.73 Billion | 2.39 Billion | 1.96 Billion | 1.75 Billion | 1.86 Billion |
| Cost of Revenue | 956.04 Million | 4.19 Billion | 1.19 Billion | 1.01 Billion | 1.03 Billion | 986.07 Million |
| Gross Profit | 928.49 Million | 3.54 Billion | 1.19 Billion | 949.96 Million | 724.89 Million | 874.25 Million |
| Operating Expenses | 1.01 Billion | 3.73 Billion | 1.09 Billion | 881.31 Million | 995.38 Million | 932.14 Million |
| Selling, General and Administrative Expenses | 1.01 Billion | - | 986.39 Million | 784.31 Million | 853.38 Million | 804.14 Million |
| Research and Development Expenses | - | - | 146.31 Million | 97 Million | 142 Million | 128 Million |
| Other Expenses | - | 1.71 Million | 1.63 Million | 2.77 Million | -4.14 Million | 1.44 Million |
| Cost and Expenses | 1.97 Billion | 7.93 Billion | 2.08 Billion | 1.89 Billion | 2.02 Billion | 1.91 Billion |
| Operating Income | -89.37 Million | -195.51 Million | 108.15 Million | 68.65 Million | -270.48 Million | -57.89 Million |
| Interest Expense | 166 Thousand | 531 Thousand | 190 Thousand | 144 Thousand | 97 Thousand | 142 Thousand |
| Income Tax Expense | -53.61 Million | 49.89 Million | 54.75 Million | 56.2 Million | 7.09 Million | 45.78 Million |
| Earnings before Tax | -64.96 Million | 158.85 Million | 82.58 Million | 73.46 Million | -316.44 Million | 146.55 Million |
| Net Income | -11.35 Million | 108.95 Million | 27.83 Million | 17.26 Million | -323.53 Million | 100.76 Million |
| Earnings Per Share Basic | -0.33 | - | 0.80 | 0.50 | -9.32 | 2.90 |
| Earnings Per Share Diluted | -0.33 | - | 0.80 | 0.50 | -9.32 | 2.90 |
| Weighted Average Shares Outstanding | 34.7 Million | 34.7 Million | 34.77 Million | 34.7 Million | 34.7 Million | 34.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.7 Million | 34.7 Million | 34.81 Million | 34.7 Million | 34.7 Million | 34.7 Million |
| Gross Margin | 0.49 | 0.46 | 0.50 | 0.48 | 0.41 | 0.47 |
| EBIT Margin | 0.01 | - | 0.07 | 0.09 | -0.16 | -0.02 |
| Profit Margin | -0.01 | 0.01 | 0.01 | 0.01 | -0.18 | 0.05 |
| EBITDA | 11.25 Million | - | 172.53 Million | 172.52 Million | -272.59 Million | -28.4 Million |
| Earnings Before Tax Margin | -0.05 | -0.03 | 0.05 | 0.03 | -0.15 | -0.03 |
N3IA
6002
CRL
688305
VANTI
002720